| CPC A61K 39/39 (2013.01) [A61K 9/19 (2013.01); A61P 35/00 (2018.01); A61K 2039/53 (2013.01); A61K 2039/55505 (2013.01)] | 18 Claims |
|
1. A vaccine composition, wherein, the vaccine composition comprises the vaccine adjuvant, and an antigen or DNA encoding the antigen; wherein the vaccine adjuvant comprises metal aluminum nanoparticles, wherein the average particle size of the metal aluminum nanoparticles is 10-1000 nm, and wherein the metal aluminum nanoparticles are composed of a metal aluminum core with zero valent aluminum (Al0) and amorphous alumina layer with a thickness of 3-5 nm on the surface.
|